MedPath

CARBETOCIN INJECTION

CARBETOCIN INJECTION

Approved
DIN Number

02489244

Drug Class

Human

Market Date

Jan 21, 2020

Company
HC

Juno Pharmaceuticals Corp.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02489244
AIG Number0132909001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H01BB03 CARBETOCIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification76:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CARBETOCINActive
Strength: 100 MCG / ML
Monograph: CARBETOCIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.